Histogen Announces Completion of Dosing Milestone in its 1b/2a Trial for Androgenic Alopecia in Men
SAN DIEGO, Sept. 10, 2020 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential […]
SAN DIEGO, Sept. 10, 2020 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential […]
NORCROSS, Ga., Sept. 10, 2020 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, […]
NOIDA, India and JOHNS CREEK, Ga., Sept. 10, 2020 (GLOBE NEWSWIRE) — EbixCash, a fully owned subsidiary of Ebix, Inc. […]
CAMBRIDGE, Mass. and NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology […]
SHANGHAI, China, Sept. 10, 2020 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS), a […]
Third Quarter Fiscal 2020 Highlights(All comparisons year-over-year unless otherwise noted)Revenues of $18.7 million compared to $22.7 millionOperating expenses decreased 16% […]
SAN CARLOS, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of […]
– ZEJULA is the only PARP inhibitor approved as monotherapy for all-comer patients in the first-line and recurrent maintenance treatment […]
SHANGHAI, China, Sept. 10, 2020 (GLOBE NEWSWIRE) — Huazhu Group Limited (Nasdaq: HTHT), a leading and fast-growing multi-brand hotel group […]
DENVER, Sept. 10, 2020 (GLOBE NEWSWIRE) — PDC Energy, Inc. (“PDC” or the “Company”) (Nasdaq:PDCE) today announced that, subject to […]